Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nano Lett ; 24(17): 5132-5138, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38588326

ABSTRACT

Nanoparticle synthesis on microfluidic platforms provides excellent reproducibility and control over bulk synthesis. While there have been plenty of platforms for producing nanoparticles (NPs) with controlled physicochemical properties, such platforms often operate in a narrow range of predefined flow rates. The flow rate limitation restricts either up-scalability for industrial production or down-scalability for exploratory research use. Here, we present a universal flow rate platform that operates over a wide range of flow rates (0.1-75 mL/min) for small-scale exploratory research and industrial-level synthesis of NPs without compromising the mixing capabilities. The wide range of flow rate is obtained by using a coaxial flow with a triangular microstructure to create a vortex regardless of the flow regime (Reynolds number). The chip synthesizes several types of NPs for gene and protein delivery, including polyplex, lipid NPs, and solid polymer NPs via self-assembly and precipitation, and successfully expresses GFP plasmid DNA in human T cells.


Subject(s)
Nanoparticles , Nanoparticles/chemistry , Humans , Microfluidic Analytical Techniques , Microfluidics/methods , T-Lymphocytes/cytology , Polymers/chemistry , DNA/chemistry
2.
Biosens Bioelectron ; 237: 115487, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37352758

ABSTRACT

Recombinase polymerase amplification (RPA) is one of the most promising diagnostic methods for pathogen detection, owing to the simplified isothermal amplification technique. Using one-step digital reverse transcription RPA (dRT-RPA) to detect viral RNA provides a fast diagnosis and absolute quantification. Here, we present a chip that purifies, digitalizes, and detects viral RNA of SARS-CoV-2 in a fully automated and sensitive manner. The chip purifies the RNA using the surface charge concept of magnet bead-RNA binding, then mixes the RNA with the amplification reagents, digitalizes the amplification mixture, and performs dRT-RPA. RNA-bead complex is transported among purification buffers that are separated by an oil phase. For reagent manipulation and mixing, a magnetic valve system is integrated on the chip, where an external magnet controls the reagent direction and time of addition. Besides, a novel vacuum system is suggested to drive and regulate the reagents into two fluid systems simultaneously in ∼2 min. We also developed a cost-effective way to perform fluorescent detection for dRT-RPA on chip by using EvaGreen® dye. With integrated heating and optical detection system, the on-chip dRT-RPA presents a sample-to-answer detection platform for absolute viral RNA quantitation in 37 min and a sensitivity as low as 10 RNA copies/µL. Hence, this platform is expected to be a useful tool for accurate and automated diagnosis of infectious diseases.


Subject(s)
Biosensing Techniques , COVID-19 , Humans , Recombinases/metabolism , Reverse Transcription , Sensitivity and Specificity , SARS-CoV-2/genetics , RNA, Viral/genetics , Nucleic Acid Amplification Techniques/methods
3.
Anal Chem ; 94(37): 12884-12889, 2022 09 20.
Article in English | MEDLINE | ID: mdl-36069050

ABSTRACT

In this study, we present a fluidic dispensing system that can automate the sequential fluidic delivery of multiple reagents for lateral flow assays. Highly sensitive assays typically require multiple solution-based sequences, including washing steps and signal amplification. However, implementation of these types of sequences on an automated and highly sensitive point-of-care testing (POCT) platform remains challenging. Our platform consists of two disposable cartridges with reagent chambers and a test strip and an instrument that has a mechanical timer to actuate the cam-follower-gear components. The timer rotation sequentially shifts the position of the chambers and loads the reagents to the test paper strip. The dispensing intervals are controlled at a variation of <1% within a total actuation time of 60 min. Unlike other POCT devices, the timing of fluid delivery in our timer-actuated platform is not dependent on the selection of substrates and reagents, and the unique approach to fluidic delivery results in no reagent overlap or carryover, minimal reagent loss, and highly accurate fluidic timing control for highly sensitive solution-based assays. As a model application, the proposed platform applies a gold enhancement solution to amplify the detection signal and detect prostate-specific antigen with a limit of detection of 86 pg/mL within 27 min. This platform provides an opportunity for solution-based POCT applications with high sensitivity, thereby satisfying the requirement for user-friendly operations in resource-limited settings.


Subject(s)
Immunologic Tests , Prostate-Specific Antigen , Gold , Humans , Immunoassay/methods , Indicators and Reagents , Male , Point-of-Care Testing
4.
Lab Chip ; 22(19): 3699-3707, 2022 09 27.
Article in English | MEDLINE | ID: mdl-36000519

ABSTRACT

This paper presents a microfluidic device that can isolate extracellular vesicles (EVs) with multiple size intervals in a simple, effective, and automated manner. We accomplish this size-selective separation using a vertically movable plunger and a rotationally movable chip. The chip has open chambers with nanoporous filters that are sequentially connected by check valves. The plunger speed is adjusted to reduce chamber pressurization in order to prevent EV deformation, thereby achieving a high separation resolution. Herein, high-purity EVs with a purity ten times higher than that of ultracentrifugation were obtained by washing three times with a high EV recovery rate of 89%. For the analysis of device performance, we used polymer nanobeads, preformed liposomes, and canine blood plasma. To demonstrate the utility of the device, we applied size-selective isolation to EVs that were secreted by endothelial cells under shear flow. The results revealed that the cells secreted more EVs of larger size, the expression of CD63 protein was higher for EVs with a larger size, and a high amount of TSG101 protein was expressed under the condition of no shear flow. This device is envisioned to facilitate molecular analysis and EV-based biomarker discovery that use various biofluids, including blood plasma, urine, and cell culture supernatants. Our device automates size-selective EV filtration that requires laborious multiple washing and separation steps.


Subject(s)
Endothelial Cells , Extracellular Vesicles , Animals , Biomarkers/metabolism , Dogs , Extracellular Vesicles/metabolism , Liposomes/metabolism , Polymers/metabolism
5.
Nanomaterials (Basel) ; 12(2)2022 Jan 17.
Article in English | MEDLINE | ID: mdl-35055303

ABSTRACT

Preventing the rapid spread of viral infectious diseases has become a major concern for global health. In this study, we present a microfluidic platform that performs an immunoassay of viral antigens in a simple, automated, yet highly sensitive manner. The device uses silica particles embedded with highly bright quantum dots (QD2) and performs the immunoassay with a vertically movable top layer and a rotating bottom layer. Through the motion of the layers and the surface tension in the liquids, reagents move from top chambers to bottom chambers and mix homogeneously. A tip in the top layer with a mobile permanent magnet moves the immune complexes comprising the magnetic beads, virus particles, and QD2 between the bottom chambers. In this way, our automated device achieves a highly sensitive magnetic bead-based sandwich immunoassay for the influenza A H1N1 virus within 32.5 min. The detection limit of our method is 5.1 × 10-4 hemagglutination units, which is 2 × 103 times more sensitive than that of the conventional hemagglutination method and is comparable to PCR. Our device is useful for the rapid and sensitive detection of infectious diseases in point-of-care applications and resource-limited environments.

6.
RSC Adv ; 9(18): 10345-10351, 2019 Mar 28.
Article in English | MEDLINE | ID: mdl-35520946

ABSTRACT

Surface tension-driven flow is widely used, owing to its spontaneous motion, in microfluidic devices with single channel structures. However, when multiple channels are used, unwanted backflow often occurs. This prevents precise and sophisticated solution flow, but has been rarely characterized. We hypothesize that, with an analytical model, the parameters that influence backflow can be systematically characterized to minimize the backflow. In a microfluidic network, inlet menisci and channels are modeled as variable pressure sources and fluidic conductors, respectively. Through the model and experiment, the influence of each network element on the backflow strength is studied. Backflow strength is affected by the interplay of multiple inlet-channel elements. With the decrease (increase) of the fluidic channel conductance (inlet size), the backflow pressure of the corresponding inlet decreases. On the other hand, backflow volume reaches its peak value during the radius change of the corresponding inlet. In networks consisting of five inlet-channel elements, backflow pressure decreases with increasing step number. Our results provide the foundations for microfluidic networks driven by the Laplace pressure of inlet menisci.

7.
Lab Chip ; 18(13): 1867-1874, 2018 06 26.
Article in English | MEDLINE | ID: mdl-29877550

ABSTRACT

A simple and effective platform that can conglomerate various microfluidic functions in a single chip is essential for many bioassays, especially for point-of-care testing applications. Here, a chip that exploits surface tension in solutions with movable top and bottom layers is presented, for use in fluid transport, mixing, maintaining metered volumes, and biomolecule capture and release. The chip has open chambers in vertically mobile top layers and rotationally mobile bottom layers to exploit surface tension in biochemical solutions, and implements control over fluid motion. To manipulate biomolecules, a vertically mobile tip with a permanent magnet at the top layer performs collection, transport, release, and dispersion of magnetic beads. Thus, the chip orchestrates various fluidic control functions without using on-chip valves and pumps that increase operational and structural complexity. To demonstrate its utility, the chip performs automated DNA extraction by obtaining genomic DNA from a sample containing cells. Our approach provides a useful and effective alternative to numerous platforms that use active and passive on-chip components for bioassays.


Subject(s)
Lab-On-A-Chip Devices , Microfluidic Analytical Techniques/instrumentation , A549 Cells , Equipment Design , Humans , Polymerase Chain Reaction/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...